About Mursla
Mursla is a company based in London (United Kingdom) founded in 2017.. Mursla has raised $547.19 thousand across 2 funding rounds from investors including Future Fund and Scheme Scoop. The company has 9 employees as of January 31, 2022. Mursla offers products and services including Dynamic Biopsy Platform and EvoLiver™ Test. Mursla operates in a competitive market with competitors including Guardant Health, GRAIL, Color, Nautilus Biotechnology and Somalogic, among others.
- Headquarter London, United Kingdom
- Employees 9 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mursla Limited
- Date of Incorporation 12 Apr, 2017
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$547.19 K (USD)
in 2 rounds
-
Latest Funding Round
$53.38 K (USD), Grant
Sep 01, 2020
-
Investors
Future Fund
& 1 more
-
Employee Count
9
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mursla
Mursla offers a comprehensive portfolio of products and services, including Dynamic Biopsy Platform and EvoLiver™ Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive platform for analyzing blood vesicles to detect cancer early.
Blood test for early liver cancer in high-risk patients with high sensitivity.
Unlock access to complete
Funding Insights of Mursla
Mursla has successfully raised a total of $547.19K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $53.38 thousand completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $53,384
-
First Round
First Round
(01 Sep 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Seed - Mursla | Valuation | Future Fund |
|
| Sep, 2020 | Amount | Grant - Mursla | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mursla
Mursla has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Future Fund and Scheme Scoop. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
News and updates on government schemes are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mursla
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mursla
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mursla Comparisons
Competitors of Mursla
Mursla operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Color, Nautilus Biotechnology and Somalogic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mursla
Frequently Asked Questions about Mursla
When was Mursla founded?
Mursla was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Mursla located?
Mursla is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Mursla a funded company?
Mursla is a funded company, having raised a total of $547.19K across 2 funding rounds to date. The company's 1st funding round was a Seed of $547.19K, raised on Sep 01, 2020.
How many employees does Mursla have?
As of Jan 31, 2022, the latest employee count at Mursla is 9.
What does Mursla do?
Mursla was founded in 2017 in London, United Kingdom, and operates in the health technology sector. A diagnostic device is being developed that employs proprietary nanostructures for non-invasive liquid biopsy. Approved protein biomarkers and semiconductor technology are utilized in large panels to enable early cancer detection. Low-cost solutions for diagnostics and personalized medicine are provided through this platform.
Who are the top competitors of Mursla?
Mursla's top competitors include Guardant Health, GRAIL and Somalogic.
What products or services does Mursla offer?
Mursla offers Dynamic Biopsy Platform and EvoLiver™ Test.
Who are Mursla's investors?
Mursla has 2 investors. Key investors include Future Fund, and Scheme Scoop.